Variant report
Variant | nsv515699 |
---|---|
Chromosome Location | chr3:22631593-22640648 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:52236011..52236894-chr3:22635315..22635889,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs377639649 | chr3:22635028-22635029 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs543593184 | chr3:22635051-22635052 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556578150 | chr3:22635094-22635095 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs13085456 | chr3:22635096-22635097 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs180768303 | chr3:22635117-22635118 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs553319642 | chr3:22635122-22635123 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541866677 | chr3:22635132-22635133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs571831274 | chr3:22635148-22635149 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs144331996 | chr3:22635166-22635167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561172535 | chr3:22635167-22635168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs576148879 | chr3:22635198-22635199 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543745879 | chr3:22635236-22635237 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs74343770 | chr3:22635239-22635240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs75162292 | chr3:22635257-22635258 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs147789558 | chr3:22635280-22635281 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs4858420 | chr3:22635282-22635283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs570599012 | chr3:22635302-22635303 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527811528 | chr3:22635312-22635313 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs568502875 | chr3:22635338-22635339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs141345614 | chr3:22635352-22635353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs34942625 | chr3:22635380-22635381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs567887466 | chr3:22635420-22635421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs67756583 | chr3:22635435-22635436 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs552346483 | chr3:22635440-22635441 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs555861935 | chr3:22635465-22635466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs78429467 | chr3:22635485-22635486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs538920972 | chr3:22635489-22635490 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs553380706 | chr3:22635507-22635508 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs116753581 | chr3:22635521-22635522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs9851085 | chr3:22635551-22635552 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
31 | rs1579988 | chr3:22635581-22635582 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs185709510 | chr3:22635586-22635587 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs190080733 | chr3:22635594-22635595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs140731144 | chr3:22635697-22635698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34256027 | chr3:22635707-22635708 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs77774972 | chr3:22635710-22635711 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs143527122 | chr3:22635751-22635752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs548510069 | chr3:22635758-22635759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs183600223 | chr3:22635803-22635804 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs527674492 | chr3:22635806-22635807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556410434 | chr3:22635818-22635819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs542963127 | chr3:22635859-22635860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs150983256 | chr3:22635937-22635938 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs35986413 | chr3:22635957-22635958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs368091197 | chr3:22635990-22635991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs531800514 | chr3:22636031-22636032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs35100704 | chr3:22636049-22636050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550132593 | chr3:22636057-22636058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs188647459 | chr3:22636060-22636061 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs532701975 | chr3:22636076-22636077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22635000-22636600 | Enhancers | HUES64 Cell Line | embryonic stem cell |
2 | chr3:22636000-22636200 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
3 | chr3:22636200-22648200 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
4 | chr3:22638600-22639200 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr3:22638600-22639200 | ZNF genes & repeats | iPS DF 19.11 Cell Line | embryonic stem cell |